UA76936C2

UA76936C2 - Human monoclonal antibody binding the antigen-4 of cytotoxic t-lymphocyte (ctla-4), nucleic acid, cell line, method of obtaining transgenic mammal, method to increase producing il-2 or ifn-? in the t-cells of a patient, method to treat and pharmaceutical composition used in treatment of cancer, inflammation or autoimmune disease, including the antibody

Human monoclonal antibody binding the antigen-4 of cytotoxic t-lymphocyte (ctla-4), nucleic acid, cell line, method of obtaining transgenic mammal, method to increase producing il-2 or ifn-? in the t-cells of a patient, method to treat and pharmaceutical composition used in treatment of cancer, inflammation or autoimmune disease, including the antibody Download PDF

Info

Publication number: UA76936C2
Authority: UA; Ukraine
Prior art keywords: antibody; amino acid; acid sequence; sequence; sti
Prior art date: 1998-12-23

Application number

UA2001075213A

Other languages

English (en)

Ukrainian (uk)

Original Assignee

Pfizer

Abgenix Inc

Priority date

1998-12-23

Filing date

1999-12-23

Publication date

2006-10-16

1999-12-23 Application filed by Pfizer, Abgenix Inc filed Critical Pfizer

2006-10-16 Publication of UA76936C2 publication Critical patent/UA76936C2/uk

Links

230000027455 binding Effects 0.000 title claims abstract description 98
238000000034 method Methods 0.000 title claims abstract description 87
210000001744 T-lymphocyte Anatomy 0.000 title claims abstract description 84
239000008194 pharmaceutical composition Substances 0.000 title claims abstract 6
241000282414 Homo sapiens Species 0.000 title claims description 156
210000004027 cell Anatomy 0.000 title claims description 112
206010028980 Neoplasm Diseases 0.000 title claims description 24
238000011282 treatment Methods 0.000 title claims description 12
150000007523 nucleic acids Chemical class 0.000 title claims description 9
102000039446 nucleic acids Human genes 0.000 title claims description 8
108020004707 nucleic acids Proteins 0.000 title claims description 8
241000124008 Mammalia Species 0.000 title claims description 6
201000011510 cancer Diseases 0.000 title claims description 5
230000009261 transgenic effect Effects 0.000 title claims description 5
208000023275 Autoimmune disease Diseases 0.000 title claims description 3
206010061218 Inflammation Diseases 0.000 title claims description 3
230000004054 inflammatory process Effects 0.000 title claims description 3
210000001151 cytotoxic T lymphocyte Anatomy 0.000 title description 2
101710135378 pH 6 antigen Proteins 0.000 title 1
102000008203 CTLA-4 Antigen Human genes 0.000 claims abstract description 4
108010021064 CTLA-4 Antigen Proteins 0.000 claims abstract description 4
125000003275 alpha amino acid group Chemical group 0.000 claims description 177
108090000623 proteins and genes Proteins 0.000 claims description 103
239000012634 fragment Substances 0.000 claims description 74
150000001413 amino acids Chemical class 0.000 claims description 58
238000012360 testing method Methods 0.000 claims description 46
238000004519 manufacturing process Methods 0.000 claims description 43
238000006467 substitution reaction Methods 0.000 claims description 39
230000014509 gene expression Effects 0.000 claims description 37
239000000427 antigen Substances 0.000 claims description 31
102000036639 antigens Human genes 0.000 claims description 31
108010002350 Interleukin-2 Proteins 0.000 claims description 30
108091007433 antigens Proteins 0.000 claims description 30
230000035772 mutation Effects 0.000 claims description 22
102000004127 Cytokines Human genes 0.000 claims description 16
108090000695 Cytokines Proteins 0.000 claims description 16
101000939500 Homo sapiens UBX domain-containing protein 11 Proteins 0.000 claims description 16
102100029645 UBX domain-containing protein 11 Human genes 0.000 claims description 16
101150060303 SOK2 gene Proteins 0.000 claims description 14
108010076504 Protein Sorting Signals Proteins 0.000 claims description 13
230000001965 increasing effect Effects 0.000 claims description 13
241000282567 Macaca fascicularis Species 0.000 claims description 7
241000282560 Macaca mulatta Species 0.000 claims description 6
241000283973 Oryctolagus cuniculus Species 0.000 claims description 4
101000628693 Homo sapiens Serine/threonine-protein kinase 25 Proteins 0.000 claims description 3
102100026737 Serine/threonine-protein kinase 25 Human genes 0.000 claims description 3
125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims description 3
125000000539 amino acid group Chemical group 0.000 claims description 2
235000011389 fruit/vegetable juice Nutrition 0.000 claims 2
230000008775 paternal effect Effects 0.000 claims 2
101100501772 Arabidopsis thaliana ESR2 gene Proteins 0.000 claims 1
102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 1
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
230000004540 complement-dependent cytotoxicity Effects 0.000 claims 1
230000007402 cytotoxic response Effects 0.000 claims 1
239000003937 drug carrier Substances 0.000 claims 1
108010044215 ethanolamine kinase Proteins 0.000 claims 1
229940079322 interferon Drugs 0.000 claims 1
108090000765 processed proteins & peptides Proteins 0.000 abstract description 69
102000004196 processed proteins & peptides Human genes 0.000 abstract description 42
230000002401 inhibitory effect Effects 0.000 abstract description 15
238000002560 therapeutic procedure Methods 0.000 abstract description 6
230000035755 proliferation Effects 0.000 abstract description 5
238000009169 immunotherapy Methods 0.000 abstract description 4
229940045513 CTLA4 antagonist Drugs 0.000 abstract 2
238000000338 in vitro Methods 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
230000004492 positive regulation of T cell proliferation Effects 0.000 abstract 1
235000001014 amino acid Nutrition 0.000 description 69
229940024606 amino acid Drugs 0.000 description 59
241000699666 Mus <mouse, genus> Species 0.000 description 52
102000004169 proteins and genes Human genes 0.000 description 48
235000018102 proteins Nutrition 0.000 description 44
241000699670 Mus sp. Species 0.000 description 30
102000000588 Interleukin-2 Human genes 0.000 description 29
108091033319 polynucleotide Proteins 0.000 description 29
102000040430 polynucleotide Human genes 0.000 description 29
239000002157 polynucleotide Substances 0.000 description 29
239000002299 complementary DNA Substances 0.000 description 25
229920001184 polypeptide Polymers 0.000 description 24
238000004458 analytical method Methods 0.000 description 23
230000000694 effects Effects 0.000 description 22
125000003729 nucleotide group Chemical class 0.000 description 22
230000006870 function Effects 0.000 description 21
210000004408 hybridoma Anatomy 0.000 description 21
239000002773 nucleotide Substances 0.000 description 21
108060003951 Immunoglobulin Proteins 0.000 description 20
230000000903 blocking effect Effects 0.000 description 20
102000018358 immunoglobulin Human genes 0.000 description 20
230000004044 response Effects 0.000 description 20
241000282693 Cercopithecidae Species 0.000 description 19
239000000872 buffer Substances 0.000 description 19
239000000203 mixture Substances 0.000 description 18
230000000638 stimulation Effects 0.000 description 18
241000894007 species Species 0.000 description 17
238000002474 experimental method Methods 0.000 description 16
239000008280 blood Substances 0.000 description 15
239000003814 drug Substances 0.000 description 15
230000028993 immune response Effects 0.000 description 15
238000012163 sequencing technique Methods 0.000 description 15
210000004369 blood Anatomy 0.000 description 14
239000003795 chemical substances by application Substances 0.000 description 14
239000000463 material Substances 0.000 description 14
241001465754 Metazoa Species 0.000 description 13
238000013459 approach Methods 0.000 description 13
230000001225 therapeutic effect Effects 0.000 description 13
108091034117 Oligonucleotide Proteins 0.000 description 12
230000015572 biosynthetic process Effects 0.000 description 12
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
230000003993 interaction Effects 0.000 description 12
230000004073 interleukin-2 production Effects 0.000 description 12
201000010099 disease Diseases 0.000 description 11
239000002609 medium Substances 0.000 description 11
230000000295 complement effect Effects 0.000 description 10
230000002950 deficient Effects 0.000 description 10
230000006698 induction Effects 0.000 description 10
230000005764 inhibitory process Effects 0.000 description 10
108020003175 receptors Proteins 0.000 description 10
102000005962 receptors Human genes 0.000 description 10
238000012216 screening Methods 0.000 description 10
108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
101000686985 Mouse mammary tumor virus (strain C3H) Protein PR73 Proteins 0.000 description 9
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 9
238000007792 addition Methods 0.000 description 9
230000016396 cytokine production Effects 0.000 description 9
230000001419 dependent effect Effects 0.000 description 9
238000011161 development Methods 0.000 description 9
239000003446 ligand Substances 0.000 description 9
230000001404 mediated effect Effects 0.000 description 9
231100000617 superantigen Toxicity 0.000 description 9
230000004614 tumor growth Effects 0.000 description 9
108020004414 DNA Proteins 0.000 description 8
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
241000288906 Primates Species 0.000 description 8
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 8
241000700605 Viruses Species 0.000 description 8
230000004913 activation Effects 0.000 description 8
230000004940 costimulation Effects 0.000 description 8
238000012217 deletion Methods 0.000 description 8
230000037430 deletion Effects 0.000 description 8
238000005516 engineering process Methods 0.000 description 8
238000005259 measurement Methods 0.000 description 8
230000002441 reversible effect Effects 0.000 description 8
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 8
239000006228 supernatant Substances 0.000 description 8
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 7
210000003719 b-lymphocyte Anatomy 0.000 description 7
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 7
108020004999 messenger RNA Proteins 0.000 description 7
238000002741 site-directed mutagenesis Methods 0.000 description 7
206010011968 Decreased immune responsiveness Diseases 0.000 description 6
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 6
150000001875 compounds Chemical class 0.000 description 6
201000002491 encephalomyelitis Diseases 0.000 description 6
239000000499 gel Substances 0.000 description 6
230000002637 immunotoxin Effects 0.000 description 6
239000002596 immunotoxin Substances 0.000 description 6
231100000608 immunotoxin Toxicity 0.000 description 6
229940051026 immunotoxin Drugs 0.000 description 6
238000004949 mass spectrometry Methods 0.000 description 6
230000002285 radioactive effect Effects 0.000 description 6
239000011347 resin Substances 0.000 description 6
229920005989 resin Polymers 0.000 description 6
238000001890 transfection Methods 0.000 description 6
239000004474 valine Substances 0.000 description 6
229960004295 valine Drugs 0.000 description 6
239000013598 vector Substances 0.000 description 6
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 5
241001529936 Murinae Species 0.000 description 5
108091028043 Nucleic acid sequence Proteins 0.000 description 5
239000004698 Polyethylene Substances 0.000 description 5
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 5
210000000612 antigen-presenting cell Anatomy 0.000 description 5
230000033228 biological regulation Effects 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
238000003776 cleavage reaction Methods 0.000 description 5
230000000139 costimulatory effect Effects 0.000 description 5
239000012636 effector Substances 0.000 description 5
231100000655 enterotoxin Toxicity 0.000 description 5
230000003053 immunization Effects 0.000 description 5
238000002649 immunization Methods 0.000 description 5
229960000310 isoleucine Drugs 0.000 description 5
210000004698 lymphocyte Anatomy 0.000 description 5
210000005087 mononuclear cell Anatomy 0.000 description 5
230000037361 pathway Effects 0.000 description 5
210000005259 peripheral blood Anatomy 0.000 description 5
239000011886 peripheral blood Substances 0.000 description 5
239000000047 product Substances 0.000 description 5
230000007017 scission Effects 0.000 description 5
210000002966 serum Anatomy 0.000 description 5
238000001542 size-exclusion chromatography Methods 0.000 description 5
150000003384 small molecules Chemical class 0.000 description 5
239000000243 solution Substances 0.000 description 5
230000004936 stimulating effect Effects 0.000 description 5
239000000126 substance Substances 0.000 description 5
230000004083 survival effect Effects 0.000 description 5
229940124597 therapeutic agent Drugs 0.000 description 5
238000011830 transgenic mouse model Methods 0.000 description 5
108091035707 Consensus sequence Proteins 0.000 description 4
101710146739 Enterotoxin Proteins 0.000 description 4
201000008808 Fibrosarcoma Diseases 0.000 description 4
239000004471 Glycine Substances 0.000 description 4
108010065805 Interleukin-12 Proteins 0.000 description 4
102000013462 Interleukin-12 Human genes 0.000 description 4
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 4
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
239000004472 Lysine Substances 0.000 description 4
108700018351 Major Histocompatibility Complex Proteins 0.000 description 4
229930182555 Penicillin Natural products 0.000 description 4
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
229920001213 Polysorbate 20 Polymers 0.000 description 4
206010060862 Prostate cancer Diseases 0.000 description 4
208000000236 Prostatic Neoplasms Diseases 0.000 description 4
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 4
239000004473 Threonine Substances 0.000 description 4
235000004279 alanine Nutrition 0.000 description 4
230000008901 benefit Effects 0.000 description 4
230000030833 cell death Effects 0.000 description 4
230000008859 change Effects 0.000 description 4
238000010367 cloning Methods 0.000 description 4
239000011248 coating agent Substances 0.000 description 4
238000000576 coating method Methods 0.000 description 4
238000010276 construction Methods 0.000 description 4
238000013461 design Methods 0.000 description 4
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
230000003828 downregulation Effects 0.000 description 4
229940079593 drug Drugs 0.000 description 4
238000001962 electrophoresis Methods 0.000 description 4
238000004520 electroporation Methods 0.000 description 4
239000000147 enterotoxin Substances 0.000 description 4
230000002255 enzymatic effect Effects 0.000 description 4
238000000684 flow cytometry Methods 0.000 description 4
238000001415 gene therapy Methods 0.000 description 4
238000003119 immunoblot Methods 0.000 description 4
230000002163 immunogen Effects 0.000 description 4
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 4
230000007246 mechanism Effects 0.000 description 4
239000013642 negative control Substances 0.000 description 4
230000009871 nonspecific binding Effects 0.000 description 4
229940049954 penicillin Drugs 0.000 description 4
239000002953 phosphate buffered saline Substances 0.000 description 4
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
230000008569 process Effects 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
230000001105 regulatory effect Effects 0.000 description 4
239000000523 sample Substances 0.000 description 4
238000010561 standard procedure Methods 0.000 description 4
229960005322 streptomycin Drugs 0.000 description 4
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 4
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
230000003612 virological effect Effects 0.000 description 4
238000005406 washing Methods 0.000 description 4
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
239000004475 Arginine Substances 0.000 description 3
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 3
-1 B -galactosidase Proteins 0.000 description 3
108010045634 B7 Antigens Proteins 0.000 description 3
102000005738 B7 Antigens Human genes 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
108091026890 Coding region Proteins 0.000 description 3
108020004705 Codon Proteins 0.000 description 3
241000699800 Cricetinae Species 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
241000282412 Homo Species 0.000 description 3
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
206010025323 Lymphomas Diseases 0.000 description 3
206010027476 Metastases Diseases 0.000 description 3
241000699660 Mus musculus Species 0.000 description 3
108090000630 Oncostatin M Proteins 0.000 description 3
206010035226 Plasma cell myeloma Diseases 0.000 description 3
241000700159 Rattus Species 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
229920002684 Sepharose Polymers 0.000 description 3
241000191940 Staphylococcus Species 0.000 description 3
230000006044 T cell activation Effects 0.000 description 3
108091008874 T cell receptors Proteins 0.000 description 3
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 3
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
230000009471 action Effects 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
230000003321 amplification Effects 0.000 description 3
239000005557 antagonist Substances 0.000 description 3
230000000692 anti-sense effect Effects 0.000 description 3
230000005875 antibody response Effects 0.000 description 3
229960001230 asparagine Drugs 0.000 description 3
235000009582 asparagine Nutrition 0.000 description 3
239000011324 bead Substances 0.000 description 3
230000001588 bifunctional effect Effects 0.000 description 3
238000004422 calculation algorithm Methods 0.000 description 3
244000309466 calf Species 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
238000007796 conventional method Methods 0.000 description 3
230000009260 cross reactivity Effects 0.000 description 3
206010012601 diabetes mellitus Diseases 0.000 description 3
230000004069 differentiation Effects 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
239000013604 expression vector Substances 0.000 description 3
239000012894 fetal calf serum Substances 0.000 description 3
238000009472 formulation Methods 0.000 description 3
238000011990 functional testing Methods 0.000 description 3
230000004927 fusion Effects 0.000 description 3
230000013595 glycosylation Effects 0.000 description 3
238000006206 glycosylation reaction Methods 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
230000001976 improved effect Effects 0.000 description 3
238000001155 isoelectric focusing Methods 0.000 description 3
210000003292 kidney cell Anatomy 0.000 description 3
238000012933 kinetic analysis Methods 0.000 description 3
238000004811 liquid chromatography Methods 0.000 description 3
239000003550 marker Substances 0.000 description 3
239000012528 membrane Substances 0.000 description 3
229930182817 methionine Natural products 0.000 description 3
201000000050 myeloid neoplasm Diseases 0.000 description 3
230000010807 negative regulation of binding Effects 0.000 description 3
238000003199 nucleic acid amplification method Methods 0.000 description 3
239000000816 peptidomimetic Substances 0.000 description 3
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 3
239000002957 persistent organic pollutant Substances 0.000 description 3
238000002823 phage display Methods 0.000 description 3
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
229920001223 polyethylene glycol Polymers 0.000 description 3
230000001172 regenerating effect Effects 0.000 description 3
238000011160 research Methods 0.000 description 3
238000000926 separation method Methods 0.000 description 3
230000011664 signaling Effects 0.000 description 3
239000007790 solid phase Substances 0.000 description 3
239000000758 substrate Substances 0.000 description 3
210000001541 thymus gland Anatomy 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
230000009466 transformation Effects 0.000 description 3
210000004881 tumor cell Anatomy 0.000 description 3
229960005486 vaccine Drugs 0.000 description 3
239000011534 wash buffer Substances 0.000 description 3
206010069754 Acquired gene mutation Diseases 0.000 description 2
102000006306 Antigen Receptors Human genes 0.000 description 2
108010083359 Antigen Receptors Proteins 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
241000283707 Capra Species 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
201000009030 Carcinoma Diseases 0.000 description 2
108010047041 Complementarity Determining Regions Proteins 0.000 description 2
238000001712 DNA sequencing Methods 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
108090000144 Human Proteins Proteins 0.000 description 2
102000003839 Human Proteins Human genes 0.000 description 2
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
108091034057 RNA (poly(A)) Proteins 0.000 description 2
108091028664 Ribonucleotide Proteins 0.000 description 2
241000283984 Rodentia Species 0.000 description 2
206010039491 Sarcoma Diseases 0.000 description 2
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
241000710960 Sindbis virus Species 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
230000017274 T cell anergy Effects 0.000 description 2
230000006052 T cell proliferation Effects 0.000 description 2
206010052779 Transplant rejections Diseases 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
239000002253 acid Substances 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
230000001093 anti-cancer Effects 0.000 description 2
229940034982 antineoplastic agent Drugs 0.000 description 2
239000002246 antineoplastic agent Substances 0.000 description 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
229940009098 aspartate Drugs 0.000 description 2
238000003556 assay Methods 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
239000000969 carrier Substances 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
230000002860 competitive effect Effects 0.000 description 2
239000003636 conditioned culture medium Substances 0.000 description 2
238000012258 culturing Methods 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
239000005547 deoxyribonucleotide Substances 0.000 description 2
125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
238000006073 displacement reaction Methods 0.000 description 2
238000010494 dissociation reaction Methods 0.000 description 2
230000005593 dissociations Effects 0.000 description 2
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
231100000673 dose–response relationship Toxicity 0.000 description 2
238000009509 drug development Methods 0.000 description 2
230000000763 evoking effect Effects 0.000 description 2
230000001605 fetal effect Effects 0.000 description 2
238000001502 gel electrophoresis Methods 0.000 description 2
210000004602 germ cell Anatomy 0.000 description 2
229930195712 glutamate Natural products 0.000 description 2
230000012010 growth Effects 0.000 description 2
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
230000013632 homeostatic process Effects 0.000 description 2
230000008348 humoral response Effects 0.000 description 2
229960002591 hydroxyproline Drugs 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
230000003832 immune regulation Effects 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
230000016784 immunoglobulin production Effects 0.000 description 2
238000011534 incubation Methods 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
230000002757 inflammatory effect Effects 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
208000032839 leukemia Diseases 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
238000013507 mapping Methods 0.000 description 2
230000035800 maturation Effects 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
238000000302 molecular modelling Methods 0.000 description 2
238000010172 mouse model Methods 0.000 description 2
238000011330 nucleic acid test Methods 0.000 description 2
239000003921 oil Substances 0.000 description 2
238000010647 peptide synthesis reaction Methods 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
239000012071 phase Substances 0.000 description 2
239000008363 phosphate buffer Substances 0.000 description 2
239000013612 plasmid Substances 0.000 description 2
239000013641 positive control Substances 0.000 description 2
239000000843 powder Substances 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
238000012545 processing Methods 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
238000000734 protein sequencing Methods 0.000 description 2
235000021251 pulses Nutrition 0.000 description 2
230000006798 recombination Effects 0.000 description 2
238000005215 recombination Methods 0.000 description 2
230000003252 repetitive effect Effects 0.000 description 2
230000000284 resting effect Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
239000002336 ribonucleotide Substances 0.000 description 2
125000002652 ribonucleotide group Chemical group 0.000 description 2
210000003705 ribosome Anatomy 0.000 description 2
230000028327 secretion Effects 0.000 description 2
230000019491 signal transduction Effects 0.000 description 2
229910052709 silver Inorganic materials 0.000 description 2
239000004332 silver Substances 0.000 description 2
230000037439 somatic mutation Effects 0.000 description 2
230000009870 specific binding Effects 0.000 description 2
210000000952 spleen Anatomy 0.000 description 2
238000003756 stirring Methods 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
230000005030 transcription termination Effects 0.000 description 2
241001430294 unidentified retrovirus Species 0.000 description 2
230000003827 upregulation Effects 0.000 description 2
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
BEJKOYIMCGMNRB-GRHHLOCNSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BEJKOYIMCGMNRB-GRHHLOCNSA-N 0.000 description 1
125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
206010004906 Biotin deficiency Diseases 0.000 description 1
241000283725 Bos Species 0.000 description 1
108700031361 Brachyury Proteins 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
208000011691 Burkitt lymphomas Diseases 0.000 description 1
240000008365 Celosia argentea Species 0.000 description 1
235000000722 Celosia argentea Nutrition 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
102000035183 Clathrin adaptor proteins Human genes 0.000 description 1
108091005769 Clathrin adaptor proteins Proteins 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
244000019459 Cynara cardunculus Species 0.000 description 1
235000019106 Cynara scolymus Nutrition 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
241001658031 Eris Species 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
108700024394 Exon Proteins 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
229920000209 Hexadimethrine bromide Polymers 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
101000992170 Homo sapiens Oncostatin-M Proteins 0.000 description 1
101000868422 Homo sapiens Sushi, nidogen and EGF-like domain-containing protein 1 Proteins 0.000 description 1
101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
101000845176 Homo sapiens Tsukushi Proteins 0.000 description 1
101000976574 Homo sapiens Zinc finger protein 131 Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
108700005091 Immunoglobulin Genes Proteins 0.000 description 1
206010062016 Immunosuppression Diseases 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
241000917703 Leia Species 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
206010062049 Lymphocytic infiltration Diseases 0.000 description 1
208000030289 Lymphoproliferative disease Diseases 0.000 description 1
102000043129 MHC class I family Human genes 0.000 description 1
108091054437 MHC class I family Proteins 0.000 description 1
102000043131 MHC class II family Human genes 0.000 description 1
108091054438 MHC class II family Proteins 0.000 description 1
101710175243 Major antigen Proteins 0.000 description 1
108090000143 Mouse Proteins Proteins 0.000 description 1
108010085220 Multiprotein Complexes Proteins 0.000 description 1
102000007474 Multiprotein Complexes Human genes 0.000 description 1
101100436483 Mus musculus Atp7a gene Proteins 0.000 description 1
101000780648 Mus musculus Protein argonaute-1 Proteins 0.000 description 1
102000006386 Myelin Proteins Human genes 0.000 description 1
108010083674 Myelin Proteins Proteins 0.000 description 1
208000009525 Myocarditis Diseases 0.000 description 1
241001325209 Nama Species 0.000 description 1
102000004140 Oncostatin M Human genes 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
101100491259 Oryza sativa subsp. japonica AP2-2 gene Proteins 0.000 description 1
206010033645 Pancreatitis Diseases 0.000 description 1
241001504519 Papio ursinus Species 0.000 description 1
UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
244000046052 Phaseolus vulgaris Species 0.000 description 1
235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
108010004729 Phycoerythrin Proteins 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
239000004365 Protease Substances 0.000 description 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
108020005067 RNA Splice Sites Proteins 0.000 description 1
102220507208 Rab11 family-interacting protein 1_M21A_mutation Human genes 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
108010091086 Recombinases Proteins 0.000 description 1
KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
102100032853 Sushi, nidogen and EGF-like domain-containing protein 1 Human genes 0.000 description 1
230000037453 T cell priming Effects 0.000 description 1
230000005867 T cell response Effects 0.000 description 1
102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 1
241000256856 Vespidae Species 0.000 description 1
102100023571 Zinc finger protein 131 Human genes 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
230000009824 affinity maturation Effects 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000000172 allergic effect Effects 0.000 description 1
230000000735 allogeneic effect Effects 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
230000008485 antagonism Effects 0.000 description 1
230000006023 anti-tumor response Effects 0.000 description 1
230000009830 antibody antigen interaction Effects 0.000 description 1
238000009175 antibody therapy Methods 0.000 description 1
230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 1
210000000628 antibody-producing cell Anatomy 0.000 description 1
239000000074 antisense oligonucleotide Substances 0.000 description 1
238000012230 antisense oligonucleotides Methods 0.000 description 1
230000005975 antitumor immune response Effects 0.000 description 1
230000006907 apoptotic process Effects 0.000 description 1
235000016520 artichoke thistle Nutrition 0.000 description 1
210000001106 artificial yeast chromosome Anatomy 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
230000006472 autoimmune response Effects 0.000 description 1
230000005784 autoimmunity Effects 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
239000012620 biological material Substances 0.000 description 1
125000004057 biotinyl group Chemical group [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
201000008275 breast carcinoma Diseases 0.000 description 1
239000000337 buffer salt Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
208000035269 cancer or benign tumor Diseases 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
UHBYWPGGCSDKFX-UHFFFAOYSA-N carboxyglutamic acid Chemical compound OC(=O)C(N)CC(C(O)=O)C(O)=O UHBYWPGGCSDKFX-UHFFFAOYSA-N 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
238000003163 cell fusion method Methods 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
230000014107 chromosome localization Effects 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
238000004737 colorimetric analysis Methods 0.000 description 1
238000002648 combination therapy Methods 0.000 description 1
238000012875 competitive assay Methods 0.000 description 1
238000004590 computer program Methods 0.000 description 1
230000003750 conditioning effect Effects 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
238000012937 correction Methods 0.000 description 1
ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
239000013632 covalent dimer Substances 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
230000037029 cross reaction Effects 0.000 description 1
DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000000412 dendrimer Substances 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
229920000736 dendritic polymer Polymers 0.000 description 1
230000001904 diabetogenic effect Effects 0.000 description 1
229910003460 diamond Inorganic materials 0.000 description 1
239000010432 diamond Substances 0.000 description 1
PGUYAANYCROBRT-UHFFFAOYSA-N dihydroxy-selanyl-selanylidene-lambda5-phosphane Chemical compound OP(O)([SeH])=[Se] PGUYAANYCROBRT-UHFFFAOYSA-N 0.000 description 1
238000007865 diluting Methods 0.000 description 1
239000000539 dimer Substances 0.000 description 1
NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
238000009510 drug design Methods 0.000 description 1
238000007876 drug discovery Methods 0.000 description 1
210000003162 effector t lymphocyte Anatomy 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
230000001712 encephalitogenic effect Effects 0.000 description 1
230000012202 endocytosis Effects 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
239000013613 expression plasmid Substances 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
235000013305 food Nutrition 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
238000010230 functional analysis Methods 0.000 description 1
238000012637 gene transfection Methods 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
210000001280 germinal center Anatomy 0.000 description 1
102000005396 glutamine synthetase Human genes 0.000 description 1
108020002326 glutamine synthetase Proteins 0.000 description 1
230000002710 gonadal effect Effects 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
108090001052 hairpin ribozyme Proteins 0.000 description 1
210000005003 heart tissue Anatomy 0.000 description 1
206010073071 hepatocellular carcinoma Diseases 0.000 description 1
231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
238000013537 high throughput screening Methods 0.000 description 1
235000012907 honey Nutrition 0.000 description 1
102000043703 human OSM Human genes 0.000 description 1
125000001841 imino group Chemical group [H]N=* 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000002519 immonomodulatory effect Effects 0.000 description 1
229940124644 immune regulator Drugs 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
238000002991 immunohistochemical analysis Methods 0.000 description 1
230000001506 immunosuppresive effect Effects 0.000 description 1
238000002513 implantation Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000008595 infiltration Effects 0.000 description 1
238000001764 infiltration Methods 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
229940117681 interleukin-12 Drugs 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
230000009545 invasion Effects 0.000 description 1
210000004153 islets of langerhan Anatomy 0.000 description 1
235000015110 jellies Nutrition 0.000 description 1
238000005304 joining Methods 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
229910052747 lanthanoid Inorganic materials 0.000 description 1
150000002602 lanthanoids Chemical class 0.000 description 1
230000003902 lesion Effects 0.000 description 1
150000002614 leucines Chemical class 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
210000005228 liver tissue Anatomy 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
210000005265 lung cell Anatomy 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
230000001926 lymphatic effect Effects 0.000 description 1
210000003712 lysosome Anatomy 0.000 description 1
230000001868 lysosomic effect Effects 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
210000003071 memory t lymphocyte Anatomy 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
238000005497 microtitration Methods 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
239000000178 monomer Substances 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
210000005012 myelin Anatomy 0.000 description 1
230000007896 negative regulation of T cell activation Effects 0.000 description 1
238000010606 normalization Methods 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
239000002674 ointment Substances 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
230000017448 oviposition Effects 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
210000004923 pancreatic tissue Anatomy 0.000 description 1
244000045947 parasite Species 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
239000006072 paste Substances 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
239000008177 pharmaceutical agent Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000037452 priming Effects 0.000 description 1
230000009696 proliferative response Effects 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
125000006239 protecting group Chemical group 0.000 description 1
108020001580 protein domains Proteins 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
238000000746 purification Methods 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
206010038038 rectal cancer Diseases 0.000 description 1
208000020615 rectal carcinoma Diseases 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
102220165148 rs191344898 Human genes 0.000 description 1
102220172709 rs201384449 Human genes 0.000 description 1
229910052707 ruthenium Inorganic materials 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000012723 sample buffer Substances 0.000 description 1
238000009738 saturating Methods 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
JRPHGDYSKGJTKZ-UHFFFAOYSA-N selenophosphoric acid Chemical compound OP(O)([SeH])=O JRPHGDYSKGJTKZ-UHFFFAOYSA-N 0.000 description 1
239000012679 serum free medium Substances 0.000 description 1
230000007781 signaling event Effects 0.000 description 1
230000009131 signaling function Effects 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229960001407 sodium bicarbonate Drugs 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000008247 solid mixture Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
230000000392 somatic effect Effects 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
238000010186 staining Methods 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000009897 systematic effect Effects 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
230000003614 tolerogenic effect Effects 0.000 description 1
238000012549 training Methods 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000007704 transition Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
150000003668 tyrosines Chemical class 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
UGCDBQWJXSAYIL-UHFFFAOYSA-N vat blue 6 Chemical compound O=C1C2=CC=CC=C2C(=O)C(C=C2Cl)=C1C1=C2NC2=C(C(=O)C=3C(=CC=CC=3)C3=O)C3=CC(Cl)=C2N1 UGCDBQWJXSAYIL-UHFFFAOYSA-N 0.000 description 1
238000012795 verification Methods 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
238000012800 visualization Methods 0.000 description 1
239000001993 wax Substances 0.000 description 1
238000002424 x-ray crystallography Methods 0.000 description 1
238000002689 xenotransplantation Methods 0.000 description 1
229910052727 yttrium Inorganic materials 0.000 description 1